Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > converting data

<< Previous

Bullboard Posts

Next >>

Comment by socksnblonds642on Aug 31, 2021 10:16am

174 Views

Post# 33787407

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:converting data

Yes to the non GLP however that delay was explained as a result of COVID. I was referring to GBM and lung cancers.

Any of us that are doing any sort of business are dealing with delays due to Covid. Some fake and some probably not.... Unfortunately we are probably all getting a lot of mixed information on this front. Having said that I think it's safe to say that clinical studies have legitimately been delayed.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario